메뉴 건너뛰기
British Journal of Dermatology
Volumn 157, Issue 6, 2007, Pages 1274-1275
Adalimumab for treatment of pyoderma gangrenosum [6]
Author keywords

Adalimumab; Pyoderma gangrenosum
Indexed keywords

ADALIMUMAB; ANTIBIOTIC AGENT; BECAPLERMIN; CYCLOSPORIN; ETANERCEPT; INFLIXIMAB; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRIAMCINOLONE; WOUND HEALING PROMOTING AGENT;
EID: 36148978629     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08212.x     Document Type: Letter
Times cited : (53)
References (10)
  • 1
    • 20844438180 scopus 로고    scopus 로고
    • Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases
    • Trent JT, Kerdel FA. Tumor necrosis factor alpha inhibitors for the treatment of dermatologic diseases. Dermatol Nurs 2005 17 : 97 107.
    • (2005) Dermatol Nurs , vol.17 , pp. 97-107
    • Trent, J.T.1    Kerdel, F.A.2
  • 2
    • 33645128368 scopus 로고    scopus 로고
    • Infliximab for the treatment of pyoderma gangrenosum: A randomised, double blind, placebo controlled trial
    • Brooklyn TN, Dunnill MG, Shetty A et al. Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 2006 55 : 505 9.
    • (2006) Gut , vol.55 , pp. 505-9
    • Brooklyn, T.N.1    Dunnill, M.G.2    Shetty, A.3
  • 3
    • 32644438058 scopus 로고    scopus 로고
    • The treatment of pyoderma gangrenosum using etanercept
    • Roy DB, Conte ET, Cohen DJ. The treatment of pyoderma gangrenosum using etanercept. J Am Acad Dermatol 2006 54 (3 Suppl. 2 S128 34.
    • (2006) J Am Acad Dermatol , vol.54 , Issue.32
    • Roy, D.B.1    Conte, E.T.2    Cohen, D.J.3
  • 4
    • 18944365123 scopus 로고    scopus 로고
    • Systemic pyoderma gangrenosum responding to infliximab and adalimumab
    • Hubbard VG, Friedmann AC, Goldsmith P. Systemic pyoderma gangrenosum responding to infliximab and adalimumab. Br J Dermatol 2005 152 : 1059 61.
    • (2005) Br J Dermatol , vol.152 , pp. 1059-61
    • Hubbard, V.G.1    Friedmann, A.C.2    Goldsmith, P.3
  • 5
    • 34347253247 scopus 로고    scopus 로고
    • Adalimumab therapy for recalcitrant pyoderma gangrenosum
    • Fonder MA, Cummins DL, Ehst BD et al. Adalimumab therapy for recalcitrant pyoderma gangrenosum. J Burns Wounds 2006 5 : e8.
    • (2006) J Burns Wounds , vol.5
    • Fonder, M.A.1    Cummins, D.L.2    Ehst, B.D.3
  • 7
    • 1942435955 scopus 로고    scopus 로고
    • Safety of tumour necrosis factor-alpha antagonists
    • Khanna D, McMahon M, Furst DE. Safety of tumour necrosis factor-alpha antagonists. Drug Saf 2004 27 : 307 24.
    • (2004) Drug Saf , vol.27 , pp. 307-24
    • Khanna, D.1    McMahon, M.2    Furst, D.E.3
  • 8
    • 7044264854 scopus 로고    scopus 로고
    • A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab
    • Scheinfeld N. A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab. J Dermatolog Treat 2004 15 : 280 94.
    • (2004) J Dermatolog Treat , vol.15 , pp. 280-94
    • Scheinfeld, N.1
  • 9
    • 33748444790 scopus 로고    scopus 로고
    • Problems encountered during anti-tumour necrosis factor therapy
    • Desai SB, Furst DE. Problems encountered during anti-tumour necrosis factor therapy. Best Pract Res Clin Rheumatol 2006 20 : 757 90.
    • (2006) Best Pract Res Clin Rheumatol , vol.20 , pp. 757-90
    • Desai, S.B.1    Furst, D.E.2
  • 10
    • 3543075236 scopus 로고    scopus 로고
    • A pilot study of adalimumab in infliximab-allergic patients
    • Youdim A, Vasiliauskas EA, Targan SR et al. A pilot study of adalimumab in infliximab-allergic patients. Inflamm Bowel Dis 2004 10 : 333 8.
    • (2004) Inflamm Bowel Dis , vol.10 , pp. 333-8
    • Youdim, A.1    Vasiliauskas, E.A.2    Targan, S.R.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.